Goldenwell Biotech, Inc. (GWLL)
OTCMKTS · Delayed Price · Currency is USD
0.6500
0.00 (0.00%)
At close: Oct 30, 2026
Goldenwell Biotech Revenue
Goldenwell Biotech had revenue of $55.00 in the twelve months ending June 30, 2026. In the year 2025, Goldenwell Biotech had annual revenue of $55.00, down -60.43%. That makes Goldenwell Biotech the 47,829th largest company in the world by revenue and 7,347th in the United States.
Revenue
55.00
Revenue Growth
-60.43%
P/S Ratio
1,170,000.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
64.35M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 55.00 | -84.00 | -60.43% |
| Dec 31, 2024 | 139.00 | -1.70K | -92.43% |
| Dec 31, 2023 | 1.84K | -45.96K | -96.16% |
| Dec 31, 2022 | 47.80K | 31.83K | 199.37% |
| Dec 31, 2021 | 15.97K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| South Dakota Soybean Processors, LLC | 827.71M |
| Hanover Foods | 330.81M |
| Elamex SA de CV | 110.74M |
| DAVIDsTEA | 43.23M |
| Starco Brands | 35.93M |
| UMeWorld | 1.04M |
| Harvard Apparatus Regenerative Technology | 982.00K |
| China Foods Holdings | 185.87K |